By admin 
RxMen, a Delhi-based men’s health tech startup, has raised Rs 5 crore (around $570K) in its seed round led by Inflection Point Ventures (IPV). The round also saw participation from SPA Family Ventures, Ankit Goel, Seven Square Ventures, along with a grant from Prosus Group. The proceeds will be used for brand building, launching RxMen-branded products, and setting up co-branded clinics. The firm targets to achieve positive EBITDA by October 2025.
Over the past 20 months, RxMen claims to have grown 100x in revenue and recently reported an MRR of $70,000 (Aug 2025), with an ARR projection of $1.7 million by FY26. It has already delivered over 30,000 consultations and is handling 6,000 consultations monthly through a network of 30 specialists in urology, psychiatry, sexology, and therapy. RxMen has also developed a Sexual Health Index (SHI), now under validation at IIT Jodhpur, built from 25,000 anonymized consultations. It reports a 95% success rate based on SHI outcomes.It will compete with Man Matters (Mosaic Wellness), Bold Care, and Traya.
About Rxman
Rxman has been founded in 2023 by Shailja Mittal. RxMen is a full-stack, clinic-led men’s health platform. It focuses on root-cause treatment across sexual health, hormones, skin, stress, and sleep.